Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose
Public ClinicalTrials.gov record NCT01823536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV, Open-label, Controlled, Multi-center Study to Evaluate the 5-year Antibody Persistence Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine at 2 to 10 Years of Age and to Assess the Immune Response to a Single Dose of Novartis MenACWY Conjugate Vaccine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this extension study, V59P20E1, the sponsor was planning to assess 5-year antibody persistence in subjects who received one or two doses of MenACWY conjugate vaccine at 2 to 10 years of age, and to evaluate response to a booster dose administered 5 years after primary vaccination in the parent study V59P20 (NCT00616421).
Study identification
- NCT ID
- NCT01823536
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 465 participants
Conditions and interventions
Conditions
Interventions
- Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 7 Years to 15 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2013 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Aug 15, 2014
2013 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300 | Bentonville | Arkansas | 72712 | — |
| 83 AR Pediatric Clinical Research 500 South University, Ste. 200 | Little Rock | Arkansas | 72205 | — |
| 32 Prem Health Research Center 9317 Firestone Blvd. | Downey | California | 90241 | — |
| 27 KY Pediatric Adult Research 201 South 5th Street, Suite 102 | Bardstown | Kentucky | 40004 | — |
| 36 Meridian Clinical Research 3319 N. 107th Street | Omaha | Nebraska | 68134 | — |
| 33 Dr. Sender's and Associates 2054 South Green Road | Cleveland | Ohio | 44121 | — |
| 31 Benchmark Research, Fort Worth 4504 Boat Club Rd., Suite 400A | Fort Worth | Texas | 76135 | — |
| 25 Benchmark Research, San Angelo 3555 Knickerbocker Rd. | San Angelo | Texas | 76904 | — |
| 65 Westside Medical 1477 N 2000 W, Suite C | Clinton | Utah | 84015 | — |
| 29 J. Lewis Research, Inc. 6360 South 3000 East, Ste. 100 | Salt Lake City | Utah | 84121 | — |
| 30 J. Lewis Research, Inc. 6360 South 3000 East, Ste. 100 | Salt Lake City | Utah | 84121 | — |
| 37 Copperview Medical Associates 3556 West 9800 South | South Jordan | Utah | 84095 | — |
| 47 Wee Care Pediatrics 1792 W. 1700 S. | Syracuse | Utah | 84075 | — |
| 34 Rockwood Clinic P S 400 East Fifth Avenue | Spokane | Washington | 99202 | — |
| 35 Rockwood Clinic-North Pediatrics 9001 N Country Homes Blvd | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01823536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01823536 live on ClinicalTrials.gov.